Stockscreener 앱 받기
14.10
0.49%
-0.07
시간 외 거래:
14.10
Dr Reddys Laboratories Ltd Adr 주식(RDY)의 최신 뉴스
Jharkhand Elections Phase 2: Richest candidate declares assets worth Rs 402 cr – Check list of top 10 wealthiest candidates - The Financial Express
Jharkhand Phase 2 Elections 2024: 122 candidates with serious criminal cases get tickets, shows ADR report - The Financial Express
ADR, GDR Listings of Indian companies - Goodreturns
Earnings call: Dr. Reddy's reports robust growth and strategic expansions By Investing.com - Investing.com Australia
Earnings call: Dr. Reddy's reports robust growth and strategic expansions - Investing.com India
Zollinger-Ellison Syndrome (Gastrinoma) Global Clinical Trials Review 2024: Country (G7 & E7), Phase, Trial Status, End Points Status and Sponsor Type - GlobeNewswire Inc.
Dr. Reddy's stock poised for recovery with new US launches and global OTC gains—BofA - Investing.com India
Dr. Reddy's stock poised for recovery with new US launches and global OTC gains—BofA By Investing.com - Investing.com South Africa
Dr. Reddy’s Labs ADR earnings missed by $0.85, revenue topped estimates - Investing.com Australia
Asian Equities Traded in the US as American Depositary Receipts Climb Higher Friday - MSN
Dr. Reddy’s shares trade ex-split today. Stock up 2% - The Economic Times
Asian Equities Traded in the US as American Depositary Receipts Rise Sharply in Friday Trading - MSN
Indian stock market: 8 things that changed for market overnight- Gift Nifty, US retail sales, ECB rate cut to Q2 results | Stock Market News - Mint
Infosys, Wipro ADRs down 3% on NYSE after Q2 results even as S&P, Dow drift near record-highs | Stock Market News - Mint
Zacks Research Issues Positive Forecast for RDY Earnings - MarketBeat
Top gainers and losers for today on October 16: HDFC Life, Dr Reddy’s Labs, Grasim lead NIFTY movers - Upstox
Denmark Basal Cell Carcinoma Treatment Market Size & Outlook, 2030 - Grand View Research
Saudi Arabia Basal Cell Carcinoma Treatment Market Size & Outlook, 2030 - Grand View Research
Haryana Election 2024: 95 candidates have serious criminal cases against them, 11 with cases of crime against women, says report - The Financial Express
Side-effects of banned drug Nimesulide still reported in children: Report | Today News - Mint
Dr. Reddy’s Announces Share Subdivision Date - TipRanks
Dr. Reddy’s Subsidiary Chirotech Dissolved - TipRanks
Haryana Elections 2024: Capt. Abhimanyu, Savitri Jindal among wealthiest candidates for October 5 polls | Mint - Mint
Assam: Mobile internet services to be disabled for eight hours on Sunday, here's why | Today News - Mint
Announcements Updates: Compliances-Reg. 39 (3)Details of Loss of Certificate / Duplicate Certificate - The Economic Times
Apni Party's Altaf Bukhari, BJP's Devender Rana among 3 richest candidates in Jammu and Kashmir assembly poll fray | Mint - Mint
Dr. Reddy's Labs ADR Sees RS Rating Rise To 72 - Investor's Business Daily
Dr. Reddy’s Empowers Employees with Stock Options - TipRanks
Deutsche Bank Appointed as Depositary Bank for the Sponsored American Depositary Receipt Program of Radiopharm Theranostics Limited - Business Wire
Mondrian Investment Partners LTD Has $11.56 Million Holdings in Dr. Reddy's Laboratories Limited (NYSE:RDY) - MarketBeat
Dr. Reddy's Laboratories Share Price Today Live Updates: Dr. Reddy's Laboratories Sees 1.48% Decline, Cu... - The Economic Times
Dr. Reddy's Laboratories Share Price Live Updates: Dr. Reddy's Laboratories Sees Minor Price Dip Amidst ... - The Economic Times
Dr. Reddy’s Shareholders Approve Stock Split - TipRanks
US FDA closes inspection of Dr Reddy’s API unit - BusinessLine
Singapore Anticoagulant Reversal Drugs Market Size & Outlook, 2027 - Grand View Research
Mexico Antiviral Drugs Market Size & Outlook, 2022-2030 - Grand View Research
The United States Antiviral Drugs Market Size & Outlook, 2030 - Grand View Research
Latin America Antiviral Drugs Market Size & Outlook, 2030 - Grand View Research
Weekly Upgrades and Downgrades - InvestorPlace
Dr. Reddy's Stock Hit All-Time High Last Month. Ready To Climb Again? - Investor's Business Daily
The United States Erythropoietin Drugs Market Size & Outlook, 2030 - Grand View Research
Volume Updates: Dr. Reddy's Laboratories Sees Significant Surge in Trading Volume - The Economic Times
Dr. Reddy’s Approves Employee Share Allotment - TipRanks
Stocks in news: Interarch, Dr Reddy's Labs, Ceigall, ONGC, Akums, Trent, Zydus Life & Uno Minda - Business Today
0.79%
0.15%
자본화:
|
볼륨(24시간):